Stock listing

Igc Pharma, Inc.

Selected listing: A1T87A · LS · EUR · DE

Igc Pharma, Inc. (Lang & Schwarz: A1T87A), Health Technology. Latest release Sep 28, 2026: IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial…

A1T87A:LSEURDEUpdated September 26, 2026

Ticker: Lang & Schwarz: A1T87A
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Igc Pharma, Inc.

IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026

September 28, 2026

IGC Pharma Reports Q2 2026 Results as CALMA Alzheimer's Trial Moves Within Six Randomizations of Enrollment Closure

August 17, 2026

IGC Pharma Strengthens Regulatory Readiness as Phase 2 CALMA Alzheimer's Trial Approaches Enrollment Closure and Q4 Topline Readout

August 11, 2026

IGC Pharma Evaluates Potential Recovery Options as Federal Jury Verdict Brings Renewed Attention to 2018 IGC Short Campaign

July 29, 2026

IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company

July 7, 2026

All Igc Pharma, Inc. news →

Research Igc Pharma, Inc.

Igc Pharma, Inc. company profile

View the public company page for Igc Pharma, Inc. on 6ix.

Igc Pharma, Inc. news

Read company news and market updates connected to Igc Pharma, Inc..

Igc Pharma, Inc. investor events

Find investor webinars, events, and replay context for Igc Pharma, Inc..